A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, Chapel Hill. As a board-certified ophthalmologist, she specializes in ...

A review reveals dangerous vitamin deficiencies post-bariatric surgery, highlighting the need for improved follow-up to ...

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...

Hello, readers! Welcome to a bonus letters column. We are happy to report that you are keeping our inboxes busy, so we’ll dive right in.

In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

A new study reveals that high eye pressure could be a key factor in the early stages of glaucoma, one of the top causes of ...

Zenyaku Kogyo Co. Ltd. has identified myosin light chain kinase family member 4 (MYLK4; SGK085) inhibitors reported to be useful for the treatment of arteriosclerosis, inflammatory bowel disease, ...

Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

I am 72 years old and in good health. Last fall, I got weak and shaky while working in my yard. It was a hot day, so my ...